Thetis Pharmaceuticals

OverviewSuggest Edit

Thetis Pharmaceuticals is a biopharmaceutical company developing therapies for gastrointestinal diseases, including inflammatory bowel disease and non-alcoholic steatohepatitis. Its proprietary HEALER platform enables the development of bioactive lipids that regulate inflammation and promote tissue repair and healing.
TypePrivate
Founded2011
HQBranford, CT, US
Websitethetispharma.com

Latest Updates

Employees (est.) (Jun 2021)6
Cybersecurity ratingAMore

Key People/Management at Thetis Pharmaceuticals

Gary Mathias

Gary Mathias

Co-Founder and Chief Executive Officer, Director
Frank C. Sciavolino

Frank C. Sciavolino

Co-Founder, President and Chief Scientific Officer, Director
Aaron Mathias

Aaron Mathias

Senior Director of Business Development
Walter Ogier

Walter Ogier

Director
Ronald Lennox

Ronald Lennox

Director
Dennis Willson

Dennis Willson

Director
Show more

Thetis Pharmaceuticals Office Locations

Thetis Pharmaceuticals has offices in Branford and Ridgefield
Branford, CT, US (HQ)
23 Business Park Dr
Ridgefield, CT, US
54 Danbury Rd #285
Show all (2)

Thetis Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2011

Thetis Pharmaceuticals total Funding

$17.3 m

Thetis Pharmaceuticals latest funding size

$2.3 m

Time since last funding

2 years ago

Thetis Pharmaceuticals investors

Thetis Pharmaceuticals's latest funding round in October 2019 was reported to be $2.3 m. In total, Thetis Pharmaceuticals has raised $17.3 m
Show all financial metrics

Thetis Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Thetis Pharmaceuticals Online and Social Media Presence

Embed Graph

Thetis Pharmaceuticals Blogs

Thetis Pharmaceuticals Announces Completion of Pre-IND Meeting with FDA for Development of its Resolvin E1 Candidate, TP-317, for Inflammatory Bowel Disease

TP-317 is a first-in-class small molecule oral therapy in development for ulcerative colitis and Crohn’s Disease RIDGEFIELD, CT – (January 20, 2021) – Thetis Pharmaceuticals (“Thetis”), a biopharmaceutical company developing novel therapies for autoimmune and inflammatory disorders, announced today …

Thetis Pharmaceuticals Receives Orphan Drug Designation for Resolvin E1 Program in Pediatric Ulcerative Colitis

Thetis’ drug candidate TP-317 is a first-in-class small molecule oral therapy in development for inflammatory bowel disease (IBD) RIDGEFIELD, CT – (December 14, 2020) – Thetis Pharmaceuticals (“Thetis”), a biopharmaceutical company developing novel therapies for autoimmune and inflammatory disorders…

Thetis Pharmaceuticals Frequently Asked Questions

  • When was Thetis Pharmaceuticals founded?

    Thetis Pharmaceuticals was founded in 2011.

  • Who are Thetis Pharmaceuticals key executives?

    Thetis Pharmaceuticals's key executives are Gary Mathias, Frank C. Sciavolino and Aaron Mathias.

  • How many employees does Thetis Pharmaceuticals have?

    Thetis Pharmaceuticals has 6 employees.

  • Who are Thetis Pharmaceuticals competitors?

    Competitors of Thetis Pharmaceuticals include Chemotargets, Lightcast Discovery and Cape Bio Pharms.

  • Where is Thetis Pharmaceuticals headquarters?

    Thetis Pharmaceuticals headquarters is located at 23 Business Park Dr, Branford.

  • Where are Thetis Pharmaceuticals offices?

    Thetis Pharmaceuticals has offices in Branford and Ridgefield.

  • How many offices does Thetis Pharmaceuticals have?

    Thetis Pharmaceuticals has 2 offices.